NDC codes

466581 NDC codes with hospital pricing data in the network.

• NDC 00409212201 — ENALAPRILAT SOLN 1.25 MG/ML (37 hospitals, 1,160–1,223 samples)
• NDC 25021-0317-20 — Labetalol Inj 5 mg/mL (IV) (98 hospitals, 349–1,222 samples)
• NDC 00009-0008-02 — pramipexole 0.5 mg Tab (8 hospitals, 1,168–1,222 samples)
• NDC 00143974601 — TERBUTALINE SULFATE INJ 1 MG/ML (197 hospitals, 132–1,221 samples)
• NDC 63323-0564-63 — Enoxaparin Inj 40 mg/0.4 mL (38 hospitals, 519–1,221 samples)
• NDC 43598-0529-11 — INJECTION, NEOSTIGMINE METHYLSULFATE, UP TO 0.5 MG (36 hospitals, 977–1,220 samples)
• NDC 55150-0174-10 — AZITHROMYCIN 500 MG IV SOLR (228 hospitals, 446–1,220 samples)
• NDC 00517003125 — CYANOCOBALAMIN 1000 MCG/ML IJ SOLN (314 hospitals, 878–1,220 samples)
• NDC 65857040001 — technetium Tc-99m-tilmanocept 250 mcg Recon soln 1 Each VIAL (106 hospitals, 932–1,220 samples)
• NDC 168035730 — Lidocaine-Prilocaine 2.5-2.5 % Crea 30 g TUBE (102 hospitals, 967–1,219 samples)
• NDC 36332-3297-66 — PROPOFOL SF 1GM/100ML INJ (2 hospitals, 1,119–1,218 samples)
• NDC 00409-1891-03 — Morphine *PF* Inj 4 mg/1 mL (UD) (94 hospitals, 876–1,218 samples)
• NDC 00074-1001-01 — lidocaine 4% (Topical) Tracheal Kit 4 mL (8 hospitals, 1,127–1,217 samples)
• NDC 00168-0078-15 — Gentamicin Oint 0.1% 15 GM (19 hospitals, 1,127–1,217 samples)
• NDC 71019-0121-02 — HEPARIN 30KU/NS 1LPMX (3 hospitals, 875–1,217 samples)
• NDC 69374-523-25 — FENTANYL IN NS 2500 MCG/250 ML INTRAVENOUS INFUSION [300602] (16 hospitals, 173–1,217 samples)
• NDC 14789-0108-10 — KCL 20MEQ/100ML PB (37 hospitals, 658–1,216 samples)
• NDC 0338001711 — DEXTROSE 5 % IN WATER (D5W) INTRAVENOUS SOLUTION (65 hospitals, 316–1,216 samples)
• NDC 0409116201 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (47 hospitals, 316–1,216 samples)
• NDC 0409116202 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (43 hospitals, 316–1,216 samples)
• NDC 0409116218 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (46 hospitals, 316–1,216 samples)
• NDC 0409116219 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (25 hospitals, 316–1,216 samples)
• NDC 0409116301 — BUPIVACAINE HCL 0.5 % (5 MG/ML) INJECTION SOLUTION (40 hospitals, 316–1,216 samples)
• NDC 0409116318 — BUPIVACAINE HCL 0.5 % (5 MG/ML) INJECTION SOLUTION (23 hospitals, 316–1,216 samples)
• NDC 0409156019 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (24 hospitals, 316–1,216 samples)
• NDC 0409156029 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (24 hospitals, 316–1,216 samples)
• NDC 0409161050 — BUPIVACAINE HCL 0.5 % (5 MG/ML) INJECTION SOLUTION (22 hospitals, 316–1,216 samples)
• NDC 0409488801 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (FOR COMPOUNDING) (SO) (36 hospitals, 316–1,216 samples)
• NDC 0409488802 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (FOR COMPOUNDING) (SO) (41 hospitals, 316–1,216 samples)
• NDC 0409488806 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (FOR COMPOUNDING) (SO) (24 hospitals, 316–1,216 samples)
• NDC 0409488820 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (FOR COMPOUNDING) (SO) (40 hospitals, 316–1,216 samples)
• NDC 0409488850 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (FOR COMPOUNDING) (SO) (39 hospitals, 316–1,216 samples)
• NDC 0990792337 — DEXTROSE 5 % IN WATER (D5W) INTRAVENOUS SOLUTION (60 hospitals, 316–1,216 samples)
• NDC 2502111504 — CLINDAMYCIN 150 MG/ML INJECTION SOLUTION (53 hospitals, 316–1,216 samples)
• NDC 4202316401 — VASOPRESSIN 20 UNIT/ML INTRAVENOUS SOLUTION (57 hospitals, 316–1,216 samples)
• NDC 5515016910 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (46 hospitals, 316–1,216 samples)
• NDC 5515017030 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (33 hospitals, 316–1,216 samples)
• NDC 5515025050 — BUPIVACAINE HCL 0.5 % (5 MG/ML) INJECTION SOLUTION (23 hospitals, 316–1,216 samples)
• NDC 6332318610 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (FOR COMPOUNDING) (SO) (43 hospitals, 316–1,216 samples)
• NDC 6332346601 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (40 hospitals, 316–1,216 samples)
• NDC 6332346603 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (32 hospitals, 316–1,216 samples)
• NDC 6332346617 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (50 hospitals, 316–1,216 samples)
• NDC 6332346637 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (40 hospitals, 316–1,216 samples)
• NDC 6332346701 — BUPIVACAINE HCL 0.5 % (5 MG/ML) INJECTION SOLUTION (25 hospitals, 316–1,216 samples)
• NDC 6332346757 — BUPIVACAINE HCL 0.5 % (5 MG/ML) INJECTION SOLUTION (48 hospitals, 316–1,216 samples)
• NDC 7012116421 — VASOPRESSIN 20 UNIT/ML INTRAVENOUS SOLUTION (55 hospitals, 316–1,216 samples)
• NDC 7012116427 — VASOPRESSIN 20 UNIT/ML INTRAVENOUS SOLUTION (47 hospitals, 316–1,216 samples)
• NDC 7128872652 — BUPIVACAINE HCL 0.5 % (5 MG/ML) INJECTION SOLUTION (20 hospitals, 316–1,216 samples)
• NDC 16729053308 — CYANOCOBALAMIN (VIT B-12) 1,000 MCG/ML INJECTION SOLUTION (71 hospitals, 901–1,216 samples)
• NDC 00781-3288-09 — CLINDAMYCIN 300MG/50ML PB (126 hospitals, 1,053–1,215 samples)